By HIMSS TV | September 15, 2020 | 5:05 PM There is a need for regulatory "agility" during the coronavirus pandemic, says Dr. Amy Abernethy, principal deputy commissioner at the U.S. FDA. Topic: Population Health, Policy and Legislation